Suramin for Autism Update: 2023 and Beyond Brought to you by the BRAIN FoundationIn partnership with PaxMedica About the event An exclusive interview with Howard Weisman, CEO of PaxMedica, on the latest developments and plans for FDA approval for suramin, a potential breakthrough treatment for...
The BRAIN Foundation at Paxmedica’s NASDAQ Closing Bell Event It was a great honor for The BRAIN Foundation to join the PaxMedica team as they rang the NASDAQ Closing Bell last week. PaxMedica is is a clinical-stage biopharmaceutical company spearheading the development of innovative...
The BRAIN Foundation Industry Seed Investment in Jelikalite The BRAIN Foundation is happy to announce our seed investment in JelikaLite for a total raise of $760,000 along with our co-investors. JelikaLite is a medical technology company with a focus on neurological health in pediatric population...